The Importance of Serum Pyruvate Kinase in Neuromuscular Diseases and Carrier States

Overview

Journal Muscle Nerve

Date 1979 Sep 1

PMID 492215

Citations 5

Authors

J Sage

Y Inati

F Samaha

Affiliations

Soon will be listed here.

Abstract

Serum pyruvate kinase activity was measured in several myopathic and denervating illnesses as well as in 86 potential carriers of Duchenne dystrophy. These data showed that in potential Duchenne carriers, the serum pyruvate kinase assay is more sensitive in younger patients, especially those under 20 years of age.

Citing Articles

A method for the detection of carriers of Duchenne muscular dystrophy--a preliminary report.

MONCKTON G, Marusyk H, Pehowich E Am J Hum Genet. 1981; 33(6):978-86.

PMID: 7325161 PMC: 1685149.

The female carrier of Duchenne muscular dystrophy.

Dubowitz V Br Med J (Clin Res Ed). 1982; 284(6327):1423-4.

PMID: 6805547 PMC: 1498325. DOI: 10.1136/bmj.284.6327.1423.

Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.

Savonitto C, Bonadonna G, Bongiovanni L, Duso E, De Grandis D Ital J Neurol Sci. 1983; 4(4):417-22.

PMID: 6674240 DOI: 10.1007/BF02125620.

Results of blind testing a method to detect carriers of the Duchenne muscular dystrophy gene.

MONCKTON G, Zatz M, Mion C, Marusyk H Am J Hum Genet. 1984; 36(4):926-30.

PMID: 6475962 PMC: 1684495.

Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Moser H Hum Genet. 1984; 66(1):17-40.

PMID: 6365739 DOI: 10.1007/BF00275183.